As MAP17 expression was highest in adenocarcinoma (Additional file 1: Figure S1), which is the lung tumour subtype with the highest prevalence, we decided to focus our work on this histological subtype. The gene discussed is PDZK1IP1; the disease is adenocarcinoma.